About this trial
Pulmonary rehabilitation (PR) is a key non-pharmacological intervention for patients with chronic obstructive pulmonary disease (COPD), yet it remains underutilized, particularly among patients living in peripheral areas due to limited access, travel distance, and logistical barriers. Tele-pulmonary rehabilitation (TPR) has the potential to improve access to care, but its feasibility and effectiveness as a group-based intervention have not been well established.
The aim of this study is to evaluate whether a group-based TPR program can improve treatment initiation and adherence compared to usual care, defined as referral to standard PR, among COPD patients living in peripheral areas. In addition, the study will assess the effect of the intervention on COPD exacerbations, symptom burden, quality of life, and patient satisfaction.
This is a prospective randomized controlled trial that will enroll patients with COPD who are eligible for PR according to the Israeli health basket criteria and have not participated in PR in the past year. Participants will be randomly assigned to one of two groups: (1) referral to standard PR (control group), or (2) participation in a 12-week, twice-weekly, group-based TPR program delivered remotely via a dedicated application and video sessions (intervention group).
Eligibility criteria
Qualifiers
FEV1 below 50%
Severe exacerbation (hospitalization) in the previous year
Two moderate exacerbations in the previous year
Willingness to initiate a PR or TPR programs.
Disqualifiers
Uncontrolled comorbidity (e.g uncontrolled congestive heart failure).
Inability to operate the mobile application.
Without a mobile device or computer.
An exacerbation in the 2-months prior to randomization.
Trial design
Treatments tested in this trial
- Tele-Rehabilitation
Treatment groups
Sponsors and collaborators
Tel-Aviv Sourasky Medical Center
Lead sponsor
The Israel National Institute For Health Policy Research
Collaborator